Company news
Kissei Pharmaceutical Co., Ltd. news in 2023
Kissei Pharmaceutical Co., Ltd.'s news releases, calls and decks from 2023, newest first.
KORSUVA® IV Injection Syringe for Dialysis 17.5μg, 25.0μg and 35.0μg to Launch in Japan for Treatment of Pruritus in Patients Undergoing Hemodialysis
December 12, 2023
Notice Concerning Revisions to Financial Results Forecast
October 26, 2023
Results of Japanese Phase III Clinical Study of KORSUVA® IV Injection for Pruritus in Patients undergoing Hemodialysis Published in NEJM Evidence
October 22, 2023
Decks in 2023
- Q2 FY2023 Earnings Presentation
Earnings · 28 slides · Nov 8, 2023
- FY2022 Earnings Presentation
Earnings · 24 slides · May 10, 2023